Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical

Carlos Platero1, M Carmen Tobar2,

  • 1Health Science Technology Group, Universidad Politécnica de Madrid, Ronda de Valencia 3, 28012, Madrid, Spain. carlos.platero@upm.es.

Brain Imaging and Behavior
|November 10, 2020
PubMed

Insights

Predicting Alzheimer's disease (AD) conversion in mild cognitive impairment (MCI) is crucial. Longitudinal models combining MRI and neuropsychological data accurately predict MCI to AD progression, improving with more data points.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Biostatistics

Background:

  • Mild cognitive impairment (MCI) presents a significant risk for progression to Alzheimer's disease (AD).
  • Early and accurate prediction of MCI to AD conversion is vital for timely intervention and disease management.
  • Identifying predictive biomarkers from multimodal data remains a challenge.

Purpose of the Study:

  • To develop and evaluate longitudinal predictive models for MCI to probable AD conversion.
  • To quantify the impact of single- and multisource data on prediction accuracy.
  • To identify a minimal set of highly predictive features for MCI conversion.

Main Methods:

  • Combined magnetic resonance imaging (MRI) markers (cortical thickness, subcortical volumes) with neuropsychological tests.
  • Utilized a linear mixed effects model to analyze longitudinal data trajectories.
  • Trained classifiers on marginal longitudinal trajectory residues of selected features.

Main Results:

  • Models achieved 77% accuracy (AUC=0.855) at baseline using selected longitudinal features.
  • Incorporating more longitudinal data improved prediction accuracy to 84% (AUC=0.912).
  • The approach was validated on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.

Conclusions:

  • Longitudinal predictive models integrating MRI and neuropsychological data show high accuracy in predicting MCI to AD conversion.
  • The predictive performance improves with the inclusion of more longitudinal data points.
  • This approach can identify key features for early AD detection in MCI patients.